XML 84 R37.htm IDEA: XBRL DOCUMENT v3.19.3
SCHEDULE OF SHARE-BASED COMPENSATION, STOCK OPTIONS AND STOCK APPRECIATION RIGHTS AWARD ACTIVITY (Details) - Stock Appreciation Rights (SARs) [Member] - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value     $ 54.63    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $ 4,948   $ 4,948    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 59.71   $ 59.71   $ 59.26
Share-based Compensation Arrangement By Share-based Payment Award, Options and Stock Appreciation Rights, Outstanding [Roll Forward]          
Beginning of Year (in shares) 1,749,201   1,749,201    
Grants in Period (in shares) 0 9,415 213,618 509,046  
Exercises in Period (in shares)     108,022    
Forfeitures in Period (in shares)     87,351    
Weighted Average Exercise Price, Exercises in Period (in dollars per share)     $ 34.84    
Weighted Average Exercise Price, Forfeitures in Period (in dollars per share)     65.96    
Weighted Average Exercise Price, Exercisable (in dollars per share) $ 59.00   $ 59.00    
Weighted Average Remaining Contractual Term, Outstanding (in years)     5 years 9 months 18 days    
Weighted Average Remaining Contractual Term, Exercisable (in years)     4 years 10 months 24 days    
Aggregate Intrinsic Value, Outstanding $ 4,948   $ 4,948    
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 2,369,878   2,369,878   2,351,633